253 publications
Ciclosporin (Ikervis®) for the treatment of severe keratitis in adult patients with the dry eye syndrome
Zorginstituut Nederland has completed its assessment whether ciclosporin (Ikervis®) for the treatment of severe keratitis in ...
Dabrafenib/trametinib (Tafinlar®/Mekinist®) for the adjuvant treatment of adult patients with stage III melanoma
Zorginstituut Nederland has completed its assessment of dabrafenib (Tafinlar®) in combination with trametinib (Mekinist®) for the ...
Explanation of the Interest Form - MEB-ZIN Parallel Procedures pilot
Accelerating patient access to reimbursable innovative medicines has been on the wish list of the government, patient ...
Erenumab (Aimovig®) for the prophylaxis of adults with migraine
Zorginstituut Nederland has completed its assessment whether erenumab (Aimovig®) for the prophylaxis of adults with migraine, can ...
Ipilimumab/nivolumab (Yervoy®/Opdivo®) for the first-line treatment of adult patients with intermediate/poor-risk advanced renal cell carcinoma
Zorginstituut Nederland has completed its assessment whether ipilimumab/nivolumab (Yervoy®/Opdivo®) for the first-line treatment ...
Venetoclax (Venclyxto®) in combination with rituximab for the treatment of chronic lymphocytic leukaemia (CLL)
Zorginstituut Nederland has completed its assessment whether venetoclax (Venclyxto®) in combination with rituximab for the ...
Lumacaftor/ivacaftor (Orkambi®) for the treatment of cystic fibrosis
Zorginstituut Nederland carried out a marginal assessment in relation to extending the specific conditions for the medicinal ...
Tezacaftor/ivacaftor (Symkevi®) with ivacaftor monopreparation (Kalydeco®) for the treatment of cystic fibrosis
Zorginstituut Nederland carried out an assessment in relation to extending the specific conditions for the medicinal product ...
Assessment of 'established medical science and medical practice’ - a technical modification
This report is a supplement to the existing Dutch assessment framework dating form 2015. It can be used to investigate whether an ...
Brexpiprazole (Rxulti®) for the treatment of schizophrenia in adults
Zorginstituut Nederland carried out a marginal assessment whether the product brexpiprazole (Rxulti®) can be accepted into the ...